|
|
|
Careers
|
Contact Us
Home
About us
Pipeline
Partnering
News / Events
Investors
Investor Home
Share Performance
News and Events
Financials
Analyst coverage
SEC filings
Corporate Governance
Information Request
Investor Tools
Print Page
E-mail Page
RSS Feeds
E-mail Alerts
IR Contacts
SEC Filings
Form F-3
BIOLINERX LTD. filed this
Form F-3
on 07/16/2015
Document Outline
Entire Document (1341.4 KB)
Subdocument 1 - F-3 - F-3
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - N/A
Page 44 - N/A
Page 45 - N/A
Page 46 - N/A
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - N/A
Page 57 - N/A
Subdocument 2 - EX-2.1 - ARTICLES OF ASSOCIATION, AS AMENDED
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Subdocument 3 - EX-4.1 - FORM OF WARRANT
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Subdocument 4 - EX-5.1 - OPINION OF YIGAL ARNON & CO.
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Subdocument 5 - EX-5.2 - OPINION OF MORRISON & FOERSTER LLP
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Subdocument 6 - EX-12.1 - COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
Page 1 - N/A
Subdocument 7 - EX-23.1 - CONSENT OF KESSELMAN AND KESSELMAN
Page 1 - N/A
Subdocument 8 - EX-25.1 - STATEMENT OF ELIGIBILITY OF THE BANK OF NEW YORK MELLON, AS TRUSTEE
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Interview with Philip Serlin, CEO
December 2016
Copyright © 2010 BioLineRx. All rights reserved |
Terms of Use
|
Privacy Policy
Web Design by: XG Media
|
Web Development : imoon